REFERENCES
- Coppack S. Diabetes mellitus in clinical biochemistry: metabolic and clinical aspects. WJ Marshall, SK Bangert. Churchill Livingstone, UK 1995; 257–280
- Weiland DA, White RD. Diabetes mellitus. Clin Fam Pract 2002; 4(3)703–752
- Carbohydrates. Diabetes in Human Biochemistry, AG Diyabet, I Biyokimyasi, T Onat, K Emerk, E Sözmen. Palme Yayincilik, Ankara 2002; 247–253
- Poon HF, Calabrese V, Scapagnini V, Butterfield DA. Free radicals and brain aging. Clin Geriatr Med 2004; 20: 329–359, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cardin R, Saccoccio G, Masutti F, Bellentani S, Farinati F, Tiribelli C. DNA oxidative damage in leukocytes correlates with the severity of HCV-related liver disease: validation in an open population study. J Hepatol 2001; 34: 587–592, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Saxena AK, Srivastata P, Kale RK, Baquer NZ. Impaired antioxidant status in diabetic rat liver. Effect of vanadate. Biochem Pharmacol 1993; 45(3)539–542, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Suciu I, Negrean V, Sampelean D. The oxidative stress in the development of diabetes chronic complications in the elderly. Rom J Intern Med 2004; 42(2)395–406, [PUBMED], [INFOTRIEVE], [CSA]
- Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000; 26: 163–176, [PUBMED], [INFOTRIEVE], [CSA]
- O’Brien RC, Luo M, Balaz N, Mercuri J. In vitro and in vivo antioxidant properties of gliclazide. J Diabet Complications 2000; 14: 201–206, [CSA], [CROSSREF]
- Collins AR, Raslova K, Somorovska M, Petrovska H, Ondrusova A, Vohnout B, Fabry R, Dusinska M. DNA damage in diabetes: correlation with a clinical marker. Free Radic Biol Med 1998; 25: 373–377, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004; 339: 1–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Simonson SG, Zhang J, Canada AT, Su Y-F, Jr, Benvenist H, Piantadosi CA. Hydrogen peroxide production by monoamine oxidase during ischemia—reperfusion in the rat brain. J Cereb Blood Flow Metab 1993; 13: 125–134, [PUBMED], [INFOTRIEVE], [CSA]
- Kimoto K, Suzuki K, Kizaki T, Hitomi Y, Ishida H, Katsuta H, Itoh E, Ookawara T, Suzuki K, Honke K, Ohno H. Gliclazide protects pancreatic β-cells from damage by hydrogen peroxide. Biochem Biophys Res Commun 2003; 303: 112–119, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ho E, Bray TM. Antioxidants, NFkappaB activation and diabetogenesis. Proc Soc Exp Biol Med 1999; 222(3)205–213, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rehman A, Nourooz-Zadeh J, Möller W, Tritschler H, Pereira P, Halliwell B. Increased oxidative damage to all DNA bases in patients with type ii diabetes mellitus. FEBS Lett 1999; 448(1)120–122, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- O’Brien RC, Luo M. The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro. Metabolism 1997; 146(12, suppl 1)22–25, [CSA]
- Prakasam A, Sethupathy S, Pugalendi KV. Effect of casearia esculenta root extract on blood glucose and plasma antioxidant status in streptozotocin diabetic rats. Pol J Pharmacol 2003; 55: 43–49, [PUBMED], [INFOTRIEVE], [CSA]
- Giugliano D, Paolisso G, Ceriello A. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19(3)257–267, [PUBMED], [INFOTRIEVE], [CSA]
- Kumar JSS, Menon VP. Effect of diabetes on levels of lipid peroxides and glycolipids in rat brain. Metabolism 1993; 42(11)1435–1439, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sim AS, Salonikas C, Naidoo D, Wilcken DEL. Improved method for plasma malondialdehyde measurement by HPLC using methyl malondialdehyde as an internal standard. J Chromatogr B 2003; 785: 337–344, [CSA], [CROSSREF]
- Stevnsner T, Thorslund T, Souza-Pinto NC, Bohr VA. Mitochondrial repair of 8-oxoguanine and changes with aging. Exp Gerontol 2002; 37: 1189–1196, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hinokio Y, Suzuki S, Hirai M, Chiba M, Hirai A, Toyota T. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications. Diabetologia 1999; 42: 995–998, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat Res 1992; 275: 331–342, [PUBMED], [INFOTRIEVE], [CSA]
- Laight DW, Carrier MJ, Anggard EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 2000; 47: 457–464, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Torres MD, Canal JR, Perez C. Oxidative stress in normal and diabetic rats. Physiol Res 1999; 48: 203–208, [PUBMED], [INFOTRIEVE], [CSA]
- Murakami H, Tamasawa N, Matsui J, Yasujima M, Suda T. Plasma oxysterols and tocopherol in patients with diabetes mellitus and hyperlipidemia. Lipids 2000; 35: 333–338, [PUBMED], [INFOTRIEVE], [CSA]
- Polidori MC. Antioxidant micronutrients in the prevention of age-related diseases. J Postgrad Med 2003; 49: 229–235, [PUBMED], [INFOTRIEVE], [CSA]
- Adeghate E, Parvez H. The effect of diabetes mellitus on the morphology and physiology of monoamine oxidase in the pancreas. Neurotoxicology 2004; 25: 167–173, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Alper G, Girgin FK, Ozgönül M, Mentes G, Ersöz B. MAO inhibitors and oxidant stress in aging brain tissue. Eur Neuropsychopharmacol 1999; 9: 247–252, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang J, Piantadosi CA. Prevention of H2O2 generation by monoamine oxidase protects against CNS O2 toxicity. J Appl Physiol 1991; 71(3)1057–1061, [PUBMED], [INFOTRIEVE], [CSA]
- Tatton W, Chalmers-Redman R, Tatton N. Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B. J Neural Transm 2003; 110: 509–515, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Carrillo MC, Kanai S, Kitani K, Ivy GO. A high dose of long term treatment with deprenyl loses its effect on antioxidant enzyme activities as well as on survivals of Fischer-344 rats. Life Sci 2000; 67: 2539–2548, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Richter C. Oxidative damage to mitochondrial DNA and its relationship to aging. Int J Biochem Cell Biol 1995; 27(7)647–653, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Signorini AM, Fondelli C, Renzoni E, Puccetti C, Cragnoli C, Giorgi C. Antioxidant effects of gliclazide, glibenclamide, and metformin in patients with type 2 diabetes mellitus. Curr Ther Res Clin Exp 2002; 63(7)411–420, [CSA], [CROSSREF]
- Qiang X, Satoh J, Sagara M, Fukuzawa M, Masuda T, Miyaguchi S, Takahashi K, Toyota T. Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats. Metab Clin Exp 1998; 47(8)977–981, [PUBMED], [INFOTRIEVE], [CSA]
- Renier G, Mamputu JC, Serri O. Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells. Metabolism 2003; 52(8, suppl 1)13–18, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mamputu JC, Renier G. Gliclazide decreases vascular smooth muscle cell dysfunction induced by cell-mediated oxidized low-density lipoprotein. Metabolism 2001; 50(6)688–695, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Renier GA, Desfaits AC, Serri O. Effect of gliclazide on monocyte-endothelium interactions in diabetes. J Diabet. Complications 2000; 14: 215–223, [CSA], [CROSSREF]
- Henry JB. Diabetes mellitus. clinical diagnosis and mangement by laboratory methods20th, JB Henry. WB Saunders, Philadephia 2001; 215
- Sözmen EY, Tanyalçin T, Onat T, Kutay F, Erlaçin S. Ethanol induced oxidative stress and membrane injury in rat erythrocytes. Eur J Clin Chem Clin Biochem 1994; 32: 741–744, [CSA]
- Kraml M. A rapid fluorometric determination of MAO. Biochem Pharmacol 1965; 14: 1684–1686, [CSA], [CROSSREF]
- Erel O. A novel automated measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277–285, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Arnoud J, Fortis I, Blachier S, Kia D, Favier A. A simultaneous determination of retinol, α-tocopherol and β-carotene in serum by isocratic high-performance liquid chromatography. J Chromatogr 1991; 572: 103–116, [CSA]
- Nishikawa T, Sasahara T, Kiritoshi S, Sonoda K, Senokuchi T, Matsuo T, Kukidome D, Wake N, Matsumura T, Miyamura N, Sakakida M, Kishikawa H, Araki E. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 2003; 26(5)1507–1512, [PUBMED], [INFOTRIEVE], [CSA]
- Thomas CE, Huber EW, Ohlweiler DF. Hydroxyl and peroxyl radical trapping by the monoamine oxidase-B inhibitors deprenyl and MDL 72,974A: implications for protection of biological substrates. Free Radic Biol Med 1997; 22(4)733–737, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kikugawa K, Yasuhara Y, Ando K, Koyama K, Hiramoto K, Suzuki M. Protective effect of supplementation of fish oil with high n-3 polyunsaturated fatty acids against oxidative stress-induced DNA damage of rat liver in vivo. J Agric Food Chem 2003; 51: 6073–6079, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- England T, Beatty E, Regnab A, Nourooz-Zadeh J, Pereira P, O’Reilly J, Wiseman H, Geissler C, Halliwell B. The steady-state levels of oxidative DNA damage and of lipid peroxidation (F2‐isoprostanes) are not correlated in healthy human subjects. Free Radical Res 2000; 32: 355–362, [CSA]
- Muruganandan S, Gupta S, Kataria M, Lal J, Gupta PK. Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology 2002; 176: 165–173, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E. Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 1997; 40: 23–29, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Olanow CW. Deprenyl in the treatment of Parkinson’s disease: clinical effects and speculations on mechanism of action. J Neural Transm Suppl 1996; 48: 75–84, [PUBMED], [INFOTRIEVE], [CSA]